InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,000.55
(
0.28%
)
US TECH 100
20,512.00
(
-0.02%
)
Dow Jones
44,087.92
(
0.40%
)
Brent Oil
72.22
(
0.83%
)
Bitcoin
92,211.66
(
4.88%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

ming1234

Send PM Follow Ignore
Followers 45
Posts 3221
Boards Moderated 0
Alias Born 02/27/2012

ming1234

Re: None

Wednesday, 01/30/2013 3:05:28 PM

Wednesday, January 30, 2013 3:05:28 PM

Post# of 158400
news
SAN DIEGO, CA, Jan 30, 2013 (MARKETWIRE via COMTEX) -- Regen BioPharma, a wholly owned subsidiary of Bio-Matrix Scientific Group Inc. (PINKSHEETS: BMSN), announced today that it will proceed with its testing the cryogenic tissue transfer procedure after an FDA advisory panel backed new controls on stem-cell Research drugs. The committee recommended prescription and testing limits in stem cell therapies, in a 19-10 vote to expand research and increase access.
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up